News
On September 22, 2023, Todd Davis, the Chief Executive Officer of Ligand Pharmaceuticals Inc (NASDAQ:LGND), purchased 4,000 shares of the company.
On August 8, 2024, Todd Davis, CEO of Ligand Pharmaceuticals Inc (NASDAQ:LGND), purchased 2,500 shares of the company, as reported in a recent SEC Filing. Following this transaction, the insider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback